Remedy Entertainment Oyj (REMEDY) Earnings Call Transcripts

25 earnings calls from August 2020 to August 11, 2026

HLSE FI Communication Services Entertainment

Remedy Entertainment Oyj's Latest Earnings Call - Q1 FY2026

In Q1 2026, Remedy Entertainment Oyj reported revenues of EUR 13.1 million, a 2% decline year-over-year, primarily due to a decrease in development fees, although game sales and royalties nearly doubled to EUR 5 million. EBITDA improved to EUR 2.9 million, while EBIT was positive at EUR 1 million, indicating a profitable quarter ahead of the launch of CONTROL Resonant. Management maintained its full-year guidance, expecting revenue and EBITDA to increase compared to the previous year, signaling confidence in upcoming game releases and marketing efforts.

Reported metrics

MetricValueContext
Revenue EUR 13.1 million (miss) vs EUR 13.4 million in Q1 2025, -2% YoY
EBITDA EUR 2.9 million (beat) vs EUR 2.6 million in Q1 2025, +11.5% YoY
EBIT EUR 1.0 million (miss) vs EUR 1.3 million in Q1 2025, -23% YoY
Game Sales and Royalties EUR 5 million (beat) vs EUR 2.5 million in Q1 2025, +100% YoY
Cash Position EUR 34 million (positive) vs EUR 30 million in Q1 2025, +13.3% YoY
Operating Cash Flow EUR 8.3 million (beat) vs EUR 4.9 million in Q1 2025, +69.4% YoY

Guidance from management

Management maintained its full-year guidance, expecting revenue and EBITDA to increase from the previous year, indicating confidence in upcoming game releases and marketing efforts.

What management said

Ladies and gentlemen, welcome to the webcast for Remedy's Q1 Business Review of 2026. My name is Aapo Kilpinen from Remedy's Investor Relations. Joining with me today are Remedy's new CEO, Jean-Charles Gaudechon, also known as JC; and then our CFO, Santtu Kallionpaa. JC will briefly introduce himself and then guide us to the quarter. Santtu will then do a deeper dive on the financials of the quarter. We'll then look ...
— Aapo Kilpinen, Q1 FY2026 earnings call
Thank you, Santtu. All right. Our outlook for 2026 is unchanged. We expect our full year revenue and EBITDA to increase from the previous year. And then handing it to Aapo for Q&A.
— Jean-Charles Gaudechon, Q1 FY2026 earnings call

What analysts pressed on

Analysts expressed concerns regarding the impact of development fee trends on future revenue stability and the potential risks associated with entering the action RPG genre with CONTROL Resonant. Additionally, there were questions about the effectiveness of the localization strategy in new markets.

Main topics on the call

Read the full Remedy Entertainment Oyj transcript (Q1 FY2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

About Remedy Entertainment Oyj

Remedy Entertainment Oyj (REMEDY) is a publicly listed company in the Entertainment industry, within the Communication Services sector. It trades on HLSE and is based in FI. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 25 calls on record spanning August 14, 2020 to August 11, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.

Earnings Call History

EarningsCalls.dev has 25 Remedy Entertainment Oyj earnings call transcripts on record, spanning August 14, 2020 to August 11, 2026. Based on this history, Remedy Entertainment Oyj reports quarterly. The most recent call on file is dated August 11, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker
REMEDY
Exchange
HLSE
Country
FI
Sector
Communication Services
Industry
Entertainment
Calls on record
25
First call
August 14, 2020
Most recent
August 11, 2026
Reporting cadence
quarterly
Quarter Date
Earnings Calls Aug 11, 2026 Read transcript
Q1 FY2026 May 5, 2026 Read transcript
Earnings Calls Feb 10, 2026 Read transcript
Q3 FY2025 Oct 29, 2025 Read transcript
Q1 FY2025 Apr 30, 2025 Read transcript
Earnings Calls Feb 12, 2025 Read transcript
Analyst/Investor Day Nov 19, 2024 Read transcript
Q3 FY2024 Nov 1, 2024 Read transcript
Earnings Calls Aug 9, 2024 Read transcript
Q1 FY2024 Apr 29, 2024 Read transcript
Q4 FY2023 Mar 20, 2024 Read transcript
Q3 FY2023 Oct 31, 2023 Read transcript
Q2 FY2023 Aug 11, 2023 Read transcript
Q1 FY2023 Apr 26, 2023 Read transcript
Earnings Calls Feb 10, 2023 Read transcript
Q3 FY2022 Oct 28, 2022 Read transcript
Earnings Calls Aug 12, 2022 Read transcript
Q1 FY2022 May 13, 2022 Read transcript
Earnings Calls Feb 11, 2022 Read transcript
Q3 FY2021 Nov 12, 2021 Read transcript
Q2 FY2021 Aug 13, 2021 Read transcript
Q1 FY2021 May 12, 2021 Read transcript
Earnings Calls Feb 12, 2021 Read transcript
Analyst/Investor Day Dec 9, 2020 Read transcript
Earnings Calls Aug 14, 2020 Read transcript